d-3-Deoxy-dioctanoylphosphatidylinositol induces cytotoxicity in human MCF-7 breast cancer cells via a mechanism that involves downregulation of the D-type cyclin-retinoblastoma pathway.

about

d-3-Deoxy-dioctanoylphosphatidylinositol induces cytotoxicity in human MCF-7 breast cancer cells via a mechanism that involves downregulation of the D-type cyclin-retinoblastoma pathway.

Item

http://www.wikidata.org/entity/Q42754344

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

d-3-Deoxy-dioctanoylphosphatid ...... cyclin-retinoblastoma pathway.

@en

d-3-Deoxy-dioctanoylphosphatid ...... cyclin-retinoblastoma pathway.

@nl

type

Item

label

d-3-Deoxy-dioctanoylphosphatid ...... cyclin-retinoblastoma pathway.

@en

d-3-Deoxy-dioctanoylphosphatid ...... cyclin-retinoblastoma pathway.

@nl

prefLabel

d-3-Deoxy-dioctanoylphosphatid ...... cyclin-retinoblastoma pathway.

@en

d-3-Deoxy-dioctanoylphosphatid ...... cyclin-retinoblastoma pathway.

@nl

P1476

d-3-Deoxy-dioctanoylphosphatid ...... cyclin-retinoblastoma pathway.

@en

P2093

Cheryl S Gradziel

http://www.w3.org/2001/XMLSchema#string

Delilah Jewel

http://www.w3.org/2001/XMLSchema#string

Fay J Dufort

http://www.w3.org/2001/XMLSchema#string

Mary F Roberts

http://www.w3.org/2001/XMLSchema#string

Peter A Jordan

http://www.w3.org/2001/XMLSchema#string

Thomas C Chiles

http://www.w3.org/2001/XMLSchema#string

P2860

The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention

Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)

Signalling through phosphoinositide 3-kinases: the lipids take centre stage

Specific binding of the Akt-1 protein kinase to phosphatidylinositol 3,4,5-trisphosphate without subsequent activation

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

Exploiting the PI3K/AKT pathway for cancer drug discovery

Ceramide mediates nanovesicle shedding and cell death in response to phosphatidylinositol ether lipid analogs and perifosine.

Defining specific lipid binding sites for a peripheral membrane protein in situ using subtesla field-cycling NMR.

Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes.

Phospholipid-binding sites of phosphatase and tensin homolog (PTEN): exploring the mechanism of phosphatidylinositol 4,5-bisphosphate activation.

P304

1808-1815

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBALIP.2016.09.001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

1861

http://www.w3.org/2001/XMLSchema#string

P50

Scott J. Miller

P577

2016-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27600289

http://www.w3.org/2001/XMLSchema#string

P921

retinoblastoma

P932

5115159

http://www.w3.org/2001/XMLSchema#string